Found 44 matching trials
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia PHASE2 This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms EARLY_PHASE1 This study aims to assess the safety profile of in vivo BCMA/GPRC5D-targete...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia PHASE1 This study is a single-center, open-label, dose-escalation study to observe...
Show More Location
Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2) PHASE3 The purpose of this study is to compare the efficacy and safety of arlo-cel...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM PHASE1 It is a single-center, open-labeled, single-arm, non-randomized investigato...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM PHASE1 It is a single-center, open-labeled, single-arm, non-randomized investigato...
Show More Location
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Learn More & Join Trial
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma PHASE1 Clinical Trial for the safety and efficacy of DeepTag-GPRC5D targeted CAR-T...
Show More Location
The first affiliated hospital of medical college of zhejiang university
Learn More & Join Trial
To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma EARLY_PHASE1 To evaluate the safety and tolerability of anti-GPRC5D-CD19 CAR-T cells inf...
Show More Location
Guangdong Second Provincial General Hospital
Learn More & Join Trial
BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma EARLY_PHASE1 This study is a single-arm, multicenter clinical trial of dose escalation a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma PHASE1 A sample of participants' T cells will be sent to a laboratory, where the c...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited protocol activities)
Learn More & Join Trial